ABSTRACT
Silver-Russell syndrome (SRS) is a growth retardation syndrome characterized by intrauterine and postnatal growth retardation, relative macrocephaly and protruding forehead, body asymmetry and feeding difficulties. Nearly 50% of cases show a hypomethylation in 11p15.5, in 10% maternal uniparental disomy of chromosome 7 is present. A significant number of patients with SRS features also exhibit chromosomal aberrations. We analyzed 43 individuals referred for SRS genetic testing by molecular karyotyping. Pathogenic variants could be detected in five of them, including a NSD1 duplication in 5q35 and a 14q32 microdeletion. NSD1 deletions are detectable in overgrowth disorders (Sotos syndrome and Beckwith-Wiedemann syndrome), whereas NSD1 duplications are associated with growth retardation. The 14q32 deletion is typically associated with Temple syndrome (TS14), but the identification of a patient in our cohort reflects the clinical overlap between TS14 and SRS. As determination of molecular subtypes is the basis for a directed counseling and therapy, the identification of pathogenic variants in >10% of the total cohort of patients referred for SRS testing and in >16% of characteristic individuals with the characteristic SRS phenotype confirms the need to apply molecular karyotyping in this cohort.
Subject(s)
Chromosomes, Human, Pair 5/genetics , Gene Duplication , Intracellular Signaling Peptides and Proteins/genetics , Nuclear Proteins/genetics , Silver-Russell Syndrome/genetics , Child, Preschool , Chromosome Deletion , Chromosomes, Human, Pair 14/genetics , Cohort Studies , Female , Genetic Testing , Histone Methyltransferases , Histone-Lysine N-Methyltransferase , Humans , Infant , Infant, Newborn , Karyotyping , Male , Phenotype , Silver-Russell Syndrome/diagnosisABSTRACT
Ellis-van Creveld syndrome (EvC, MIM 225500) is an autosomal recessive skeletal dysplasia characterized by short limbs, short ribs, postaxial polydactyly and dysplastic nails and teeth. Congenital cardiac defects, most commonly a defect of primary atrial septation producing a common atrium, occur in 60% of affected individuals. The disease was mapped to chromosome 4p16 in nine Amish subpedigrees and single pedigrees from Mexico, Ecuador and Brazil. Weyers acrodental dysostosis (MIM 193530), an autosomal dominant disorder with a similar but milder phenotype, has been mapped in a single pedigree to an area including the EvC critical region. We have identified a new gene (EVC), encoding a 992-amino-acid protein, that is mutated in individuals with EvC. We identified a splice-donor change in an Amish pedigree and six truncating mutations and a single amino acid deletion in seven pedigrees. The heterozygous carriers of these mutations did not manifest features of EvC. We found two heterozygous missense mutations associated with a phenotype, one in a man with Weyers acrodental dysostosis and another in a father and his daughter, who both have the heart defect characteristic of EvC and polydactyly, but not short stature. We suggest that EvC and Weyers acrodental dysostosis are allelic conditions.
Subject(s)
Chromosomes, Human, Pair 4/genetics , Dysostoses/genetics , Ellis-Van Creveld Syndrome/genetics , Ethnicity/genetics , Genes , Membrane Proteins/genetics , Tooth Abnormalities/genetics , Alternative Splicing , Amino Acid Sequence , Amino Acid Substitution , Base Sequence , Brazil/epidemiology , Chromosome Mapping , Dwarfism/genetics , Ellis-Van Creveld Syndrome/ethnology , Expressed Sequence Tags , Female , Fingers/abnormalities , Genes, Dominant , Heart Defects, Congenital/genetics , Heterozygote , Humans , Incisor/abnormalities , Leucine Zippers/genetics , Male , Membrane Proteins/physiology , Microsatellite Repeats , Molecular Sequence Data , Pedigree , Pennsylvania/epidemiology , Phenotype , Point Mutation , Polymorphism, Single-Stranded Conformational , Proteins , Recombination, Genetic , Reverse Transcriptase Polymerase Chain Reaction , SyndromeABSTRACT
Anorectal malformations (ARM) encompass a broad clinical spectrum which ranges from mild anal stenosis to severe anorectal anomalies such as complex cloacal malformations. The overall incidence of ARM is around 1 in every 2,500 live births. Although causative genes for a few syndromic forms have been identified, the molecular genetic background of most ARM remains unknown. The present report describes a patient with a de novo 13.2-Mb deletion of chromosome 18q22.3-qter and a 2.2-Mb de novo duplication of chromosomal region 18pter-p11.32 located at the telomeric end of chromosome 18q. The patient presented with ARM and the typical features of 18q- syndrome (De-Grouchy syndrome). The combination of a partial duplication of the short arm and a partial deletion of the long arm of chromosome 18 has been described in 16 previous cases. However, this is the first report of an association between this complex chromosomal rearrangement and ARM.
Subject(s)
Anal Canal/abnormalities , Chromosomes, Human, Pair 18 , Rectum/abnormalities , Trisomy , Humans , In Situ Hybridization, Fluorescence , Infant, Newborn , Karyotyping , MaleABSTRACT
Cardio-facio-cutaneous (CFC) and Costello syndrome (CS) are congenital disorders with a significant clinical overlap. The recent discovery of heterozygous mutations in genes encoding components of the RAS-RAF-MAPK pathway in both CFC and CS suggested a similar underlying pathogenesis of these two disorders. While CFC is heterogeneous with mutations in BRAF, MAP2K1, MAP2K2 and KRAS, HRAS alterations are almost exclusively associated with CS. We carried out a comprehensive mutation analysis in 51 CFC-affected patients and 31 individuals with CS. Twelve different BRAF alterations were found in twenty-four patients with CFC (47.0%), two MAP2K1 mutations in five (9.8%) and two MAP2K2 sequence variations in three CFC-affected individuals (5.9%), whereas three patients had a KRAS alteration (5.9%). We identified four different missense mutations of HRAS in twenty-eight cases with CS (90.3%), while KRAS mutations were detected in two infants with a phenotype meeting criteria for CS (6.5%). In 14 informative families, we traced the parental origin of HRAS alterations and demonstrated inheritance of the mutated allele exclusively from the father, further confirming a paternal bias in the parental origin of HRAS mutations in CS. Careful clinical evaluation of patients with BRAF and MAP2K1/2 alterations revealed the presence of slight phenotypic differences regarding craniofacial features in MAP2K1- and MAP2K2-mutation positive individuals, suggesting possible genotype-phenotype correlations.
Subject(s)
Abnormalities, Multiple/genetics , Facies , Heart Defects, Congenital/genetics , Mutation , Skin Abnormalities/genetics , Adult , Child , DNA Mutational Analysis , Developmental Disabilities , Humans , Intellectual Disability , MAP Kinase Kinase 1/genetics , MAP Kinase Kinase 2/genetics , Phenotype , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins B-raf/genetics , Proto-Oncogene Proteins p21(ras) , Syndrome , ras Proteins/geneticsABSTRACT
BACKGROUND: In patients with juvenile polyposis syndrome (JPS) the frequency of large genomic deletions in the SMAD4 and BMPR1A genes was unknown. METHODS: Mutation and phenotype analysis was used in 80 unrelated patients of whom 65 met the clinical criteria for JPS (typical JPS) and 15 were suspected to have JPS. RESULTS: By direct sequencing of the two genes, point mutations were identified in 30 patients (46% of typical JPS). Using MLPA, large genomic deletions were found in 14% of all patients with typical JPS (six deletions in SMAD4 and three deletions in BMPR1A). Mutation analysis of the PTEN gene in the remaining 41 mutation negative cases uncovered a point mutation in two patients (5%). SMAD4 mutation carriers had a significantly higher frequency of gastric polyposis (73%) than did patients with BMPR1A mutations (8%) (p<0.001); all seven cases of gastric cancer occurred in families with SMAD4 mutations. SMAD4 mutation carriers with gastric polyps were significantly older at gastroscopy than those without (p<0.001). In 22% of the 23 unrelated SMAD4 mutation carriers, hereditary hemorrhagic telangiectasia (HHT) was also diagnosed clinically. The documented histologic findings encompassed a wide distribution of different polyp types, comparable with that described in hereditary mixed polyposis syndromes (HMPS). CONCLUSIONS: Screening for large deletions raised the mutation detection rate to 60% in the 65 patients with typical JPS. A strong genotype-phenotype correlation for gastric polyposis, gastric cancer, and HHT was identified, which should have implications for counselling and surveillance. Histopathological results in hamartomatous polyposis syndromes must be critically interpreted.
Subject(s)
Bone Morphogenetic Protein Receptors, Type I/genetics , Chromosome Deletion , Gastrointestinal Neoplasms/genetics , Intestinal Polyposis/genetics , Neoplastic Syndromes, Hereditary/genetics , PTEN Phosphohydrolase/genetics , Smad4 Protein/genetics , Adolescent , Adult , Age of Onset , Antigens, CD , Bone Morphogenetic Protein Receptors, Type I/deficiency , Cadherins/genetics , Child , Child, Preschool , DNA Mutational Analysis , Female , Gastrointestinal Neoplasms/epidemiology , Genetic Heterogeneity , Genotype , Germany/epidemiology , Humans , Infant , Intestinal Polyposis/epidemiology , Male , Neoplastic Syndromes, Hereditary/epidemiology , Nucleic Acid Amplification Techniques , PTEN Phosphohydrolase/deficiency , Phenotype , Point Mutation , Smad4 Protein/deficiency , Telangiectasia, Hereditary Hemorrhagic/epidemiology , Telangiectasia, Hereditary Hemorrhagic/geneticsSubject(s)
Genomic Imprinting , Proteins/genetics , Silver-Russell Syndrome/genetics , Alleles , Chromosomes, Human, Pair 7 , Humans , MaleABSTRACT
Cohen syndrome (CS) is an autosomal recessive disorder with variability in the clinical manifestations, characterised by mental retardation, postnatal microcephaly, facial dysmorphism, pigmentary retinopathy, myopia, and intermittent neutropenia. Mutations in the gene COH1 have been found in an ethnically diverse series of patients. Brief clinical descriptions of 24 patients with CS are provided. The patients were from 16 families of different ethnic backgrounds and between 2.5 and 60 years of age at assessment. DNA samples from all patients were analysed for mutations in COH1 by direct sequencing. Splice site mutations were characterised using reverse transcriptase PCR analysis from total RNA samples. In this series, we detected 25 different COH1 mutations; 19 of these were novel, including 9 nonsense mutations, 8 frameshift mutations, 4 verified splice site mutations, 3 larger in frame deletions, and 1 missense mutation. We observed marked variability of developmental and growth parameters. The typical facial gestalt was seen in 23/24 patients. Early onset progressive myopia was present in all the patients older than 5 years. Widespread pigmentary retinopathy was found in 12/14 patients assessed over 5 years of age. We present evidence for extended allelic heterogeneity of CS, with the vast majority of mutations leading to premature termination codons in COH1. Our data confirm the broad clinical spectrum of CS with some patients lacking even the characteristic facial gestalt and pigmentary retinopathy at school age.
Subject(s)
Abnormalities, Multiple/diagnosis , Intellectual Disability/diagnosis , Membrane Proteins/genetics , Myopia/diagnosis , Retinitis Pigmentosa/diagnosis , Abnormalities, Multiple/genetics , Adolescent , Adult , Child , Child, Preschool , DNA Mutational Analysis , Face/abnormalities , Female , Genetic Heterogeneity , Humans , Intellectual Disability/genetics , Male , Middle Aged , Mutation , Myopia/genetics , Phenotype , Polymorphism, Single Nucleotide , Retinitis Pigmentosa/genetics , Syndrome , Vesicular Transport ProteinsABSTRACT
An expanded polyglutamine domain in the TATA-binding protein (TBP) has been described in patients with spinocerebellar ataxia type 17 (SCA17) characterized by cerebellar ataxia associated with dementia. TBP is a general transcription initiation factor that regulates the expression of most eukaryotic genes transcribed by RNA polymerase II. SCA17, as an autosomal dominantly inherited progressive neurodegenerative disorder, is caused by heterozygous expansion of a CAG repeat coding for glutamine. Alleles with 27 to a maximum of 44 glutamine residues were found as the normal range, whereas expansions above 45 repeat units were considered pathological. Here, we present a patient with a very severe phenotype with a late onset but rapidly progressing ataxia associated with dementia and homozygous 47 glutamine residues caused by an apparent partial isodisomy 6. This extraordinary case has important implications for the insights of TBP and SCA17. The expanded polyglutamine domain in both TBP copies is not correlated with embryonic death indicating that the normal function of the protein is not disrupted by this kind of mutation but may account for the dementia seen in this patient.
Subject(s)
Chromosome Aberrations , Chromosomes, Human, Pair 6 , Spinocerebellar Ataxias/genetics , TATA-Binding Protein Associated Factors/genetics , Trinucleotide Repeat Expansion , Adult , Age of Onset , Dementia/complications , Dementia/genetics , Female , Homozygote , Humans , Microsatellite Repeats , Peptide Initiation Factors/genetics , Peptides/geneticsABSTRACT
Léri-Weill syndrome (LWS) or dyschondrosteosis represents a short stature syndrome characterised by the mesomelic shortening of the forearms and lower legs and by bilateral Madelung deformity of the wrists. Recently, mutations in the pseudoautosomal homeobox gene SHOX have been shown to be causative for this disorder. This gene has previously been described as the short stature gene implicated in Turner syndrome (TS). We studied 32 Léri-Weill patients from 18 different German and Dutch families and present clinical, radiological and molecular data. Phenotypic inter- and intrafamilial heterogeneity is a frequent finding in LWS, and phenotypic manifestations are generally more severe in females. In males, muscular hypertrophy is a frequent finding. To test for SHOX mutations we used FISH, Southern blot and SSCP analysis as well as long-range PCR and sequencing. We identified (sub)microscopic deletions encompassing the SHOX gene region in 10 out of 18 families investigated. Deletion sizes varied between 100 kb and 9 Mb and did not correlate with the severity of the phenotype. We did not detect SHOX mutations in almost half (41%) the LWS families studied, which suggests different genetic etiologies.
Subject(s)
Homeodomain Proteins/genetics , Osteochondrodysplasias/genetics , Adolescent , Adult , Blotting, Southern , Body Height/genetics , Bone and Bones/diagnostic imaging , Child , Chromosome Deletion , DNA Mutational Analysis , Female , Forearm/diagnostic imaging , Genetic Variation , Humans , In Situ Hybridization, Fluorescence , Magnetic Resonance Imaging , Male , Middle Aged , Osteochondrodysplasias/diagnostic imaging , Pedigree , Phenotype , Polymerase Chain Reaction , Polymorphism, Single-Stranded Conformational , Radiography , Sequence Deletion , Sex Chromosomes/genetics , Short Stature Homeobox Protein , SyndromeABSTRACT
OBJECTIVE: To describe mental retardation and microcephaly as initial clinical signs in myotonic dystrophy (MD) with high trinucleotide repeats. PATIENTS AND METHODS: Two patients with maternally inherited MD were examined. Southern blot analysis was performed and trinucleotide repeat expansions were related to the findings of clinical and magnetic resonance imaging investigations. RESULTS: Both patients had the large CTG trinucleotide repeat expansions often seen in congenital MD, but they lacked the typical clinical signs. Mental retardation and microcephaly were the leading features present in infancy. Muscular weakness, in contrast, developed after age 35 years. Although there was no evidence for perinatal asphyxia or sleep apnea, magnetic resonance imaging disclosed reduced brain volume and subcortical demyelination. CONCLUSIONS: Mental retardation preceding the development of muscle weakness suggests that the cerebral involvement in MD is a direct consequence of the genetic disorder and not mediated by muscle disease. Careful clinical examination of the parents for signs of MD should be considered in patients with cognitive deficits even without apparent muscular involvement.
Subject(s)
Intellectual Disability/genetics , Myotonic Dystrophy/genetics , Trinucleotide Repeats , Adult , Female , Humans , Middle AgedABSTRACT
We report on 2 sisters with an autosomal-recessive multiple pterygium syndrome, type Escobar, consisting of multiple pterygia with severe contractures, short stature, and minor facial and external genital anomalies. The striking finding was severe muscular atrophy. We speculate that a neuromuscular disorder is the underlying pathogenesis of Escobar syndrome.
Subject(s)
Abnormalities, Multiple/physiopathology , Abnormalities, Multiple/genetics , Arthrogryposis/physiopathology , Body Height , Child , Face/abnormalities , Female , Genitalia, Female/abnormalities , Hand Deformities, Congenital/physiopathology , Humans , Infant, Newborn , SyndromeABSTRACT
We describe a 10-month-old boy with an unclassified form of radial aplasia with absent thumbs, tibia hypo/-aplasia, and partial absence of toes. Only a few cases with similar limb deficiencies have been published. We try to classify the malformations on the basis of embryological considerations and discuss possible differential diagnosis.
Subject(s)
Foot Deformities, Congenital/genetics , Hand Deformities, Congenital/genetics , Radius/abnormalities , Thumb/abnormalities , Tibia/abnormalities , Toes/abnormalities , Adult , Female , Follow-Up Studies , Foot Deformities, Congenital/diagnostic imaging , Hand Deformities, Congenital/diagnostic imaging , Hemangioma/genetics , Humans , Infant , Male , Pedigree , Radiography , Tibia/diagnostic imagingABSTRACT
Among the lipodystrophies, the Barraquer-Simons syndrome is a rare condition. We describe a 27-year-old woman with progressive loss of subcutaneous fat after 15 years first affecting the face and spreading to the upper part of the body. She also suffered from deafness and had marked changes in cranial MRI. We discuss possible differential diagnosis such as the Cockayne, SHORT and Berardinelli-Seip syndrome.
Subject(s)
Deafness/diagnosis , Lipodystrophy/diagnosis , Adult , Brain/pathology , Deafness/pathology , Deafness/physiopathology , Diagnosis, Differential , Female , Gliosis , Humans , Karyotyping , Lipodystrophy/pathology , Lipodystrophy/physiopathology , Magnetic Resonance Imaging , SyndromeABSTRACT
Constitutional interstitial deletions of 5q are uncommon. The corresponding phenotype is not well defined. But severe mental retardation seems to be a consistent manifestation. We describe a 4-year-old girl with a de novo deletion of 5q33.3q35.1 presenting only with mild psychomotor delay, minor facial anomalies, and seizures.
Subject(s)
Chromosome Deletion , Chromosomes, Human, Pair 5/genetics , Intellectual Disability/genetics , Adult , Child, Preschool , Cytogenetic Analysis , Female , Humans , In Situ Hybridization, Fluorescence , Intellectual Disability/pathology , Karyotyping , MaleABSTRACT
We report on a mother and her 5-year old son, both with a terminal deletion of the short arm of the X chromosome. By molecular genetic analysis the breakpoint was located distal to steroid sulfatase gene. The boy manifested, due to nullisomy of this region, short stature (SHOX), chondrodysplasia punctata (ARSE), and mental retardation (putative mental retardation gene MRX 49). Short stature is present in mother and son, but both also had bilateral Madelung deformity, a key finding in the Léri-Weill syndrome. We discuss the phenotype in relationship to hitherto published cases with chromosomal aberrations and contiguous gene syndromes of Xp22.3.
Subject(s)
Sex Chromosome Aberrations/diagnosis , X Chromosome , Abnormalities, Multiple/genetics , Adult , Bone and Bones/abnormalities , Child, Preschool , Chromosome Deletion , Deafness/genetics , Female , Forearm/diagnostic imaging , Homeodomain Proteins/genetics , Humans , In Situ Hybridization, Fluorescence , Male , Mental Disorders/genetics , Radiography , Seizures/genetics , Short Stature Homeobox Protein , SyndromeABSTRACT
PURPOSE: Substantial clinical evidence shows the efficacy of low dose radiotherapy (RT) in the treatment of painful osteoarthritis. Experimental investigations into these empirically clinical observations remain scarce. This study investigated in vivo the effects of daily 5 x 1.0 Gy versus 5 x 0.5 Gy on adjuvant induced arthritis in rats in order to explore whether there is a dose dependence of anti-inflammatory efficacy. MATERIALS AND METHODS: Adjuvant arthritis in female Lewis rats was induced by intradermal injection of heat inactivated Mycobacterium tuberculosis on day 0. Both hind paws were X-irradiated daily from days 15 to 19 after induction according to four protocols (15 animals/group): group 1, 5 x 1.0 Gy (non-arthritic animals); group 2, sham-irradiated control; group 3, 5 x 1.0 Gy; group 4, 5 x 0.5 Gy. The clinical parameters arthritis score (AS), hind paw volume (HPV), body weight, and erythrocyte sedimentation rate (ESR) were determined. On days 21 and 30 histological sections of at least 12 ankle joints per group were analysed semi-quantitatively. RESULTS: Local irradiation of non-arthritic rats (group 1) with 5 x 1 Gy did not induce any arthritic signs. Sham-irradiated arthritic rats (group 2) showed a full-blown arthritic syndrome. Treatment of arthritic rats with 5 x 1 Gy (group 3) or 5 x 0.5 Gy (group 4) led to a reduction of mean AS from day 21 to 29 compared with group 2 (days 27-29--group 3: p=0.037; group 4: p=0.034), with no differences in efficacy between groups 3 and 4. Concurrently, following radiation treatment there was no further increase in HPV. At the end of the observation period, this effect demonstrated a dose-dependent level of significance (days 27-29--group 3: p=0.0036; group 4: p=0.039). A significant decrease in the ESR was noted in both irradiated arthritic groups on day 21 (group 3: p=0.015; group 4: p=0.006). The histopathological analysis revealed a highly significant reduction of cartilage and bone destruction on day 30 in both irradiated groups. CONCLUSIONS: This study confirms by objective criteria the anti-inflammatory efficacy of low dose RT and gives some indication for a dose dependence of its efficacy.
Subject(s)
Arthritis, Experimental/radiotherapy , Animals , Arthritis, Experimental/microbiology , Arthritis, Experimental/physiopathology , Female , Mycobacterium tuberculosis , Radiotherapy Dosage , Rats , Rats, Inbred LewABSTRACT
We evaluated the clinical features, molecular defects, and problems associated with the management of two patients who had type-VII Ehlers-Danlos syndrome and reviewed the cases of eighteen patients with this condition who had been reported on previously. The typical clinical features associated with this syndrome include bilateral congenital dislocation of the hip; severe generalized hypermobility of the joints; multiple dislocations of joints other than the hip; muscular hypotonia; and hyperelasticity, fragility, and a doughy texture of the skin. Collagen and DNA analyses demonstrated that both of our patients had type-VIIB Ehlers-Danlos syndrome, which is caused by heterozygous new mutations of the COL1A2 gene that encodes the proalpha2(I) chain of type-I procollagen. The obligatory GT dinucleotide at the splice donor site of intron 6 was altered in both of our patients: one patient (Case 1) had an A substitution of the G nucleotide, and the other patient (Case 2) had a C substitution of the T nucleotide. Abnormal splicing resulted in the loss of the exon 6-encoded N-telopeptide, which includes the N-proteinase cleavage site. Despite multiple operative procedures, one of our patients, who was thirty-seven years old at the time of the most recent follow-up, continued to have persistent subluxation of the right hip and osteoarthritis of the left hip. Closed reduction of the dislocated hips, regardless of the type of immobilization used, was unsuccessful in all twenty patients. The results of open reduction were improved when capsulorrhaphy was combined with iliac or femoral osteotomy, or both.
Subject(s)
Ehlers-Danlos Syndrome/genetics , Ehlers-Danlos Syndrome/surgery , Mutation , Procollagen/genetics , Adult , Alleles , Diagnosis, Differential , Ehlers-Danlos Syndrome/classification , Ehlers-Danlos Syndrome/complications , Ehlers-Danlos Syndrome/diagnosis , Hip Dislocation, Congenital/etiology , Hip Dislocation, Congenital/surgery , Humans , Infant , Male , Surgical Procedures, Operative/methodsSubject(s)
Heart Defects, Congenital/genetics , Limb Deformities, Congenital/genetics , Mutation/genetics , Chromosome Mapping , Chromosomes, Human, Pair 12/genetics , DNA Mutational Analysis , Exons/genetics , Female , Genetic Testing , Genetic Variation/genetics , Genotype , Heart Block/genetics , Heart Septal Defects/genetics , Humans , Introns/genetics , Male , Molecular Sequence Data , Pedigree , Phenotype , Polymorphism, Single-Stranded Conformational , Syndactyly/genetics , SyndromeABSTRACT
BACKGROUND: Lissencephaly is a neuronal migration disorder leading to absent or reduced gyration and a broadened but poorly organized cortex. The most common form of lissencephaly is isolated, referred as classic or type 1 lissencephaly. Type 1 lissencephaly is mostly associated with a heterozygous deletion of the entire LIS1 gene, whereas intragenic heterozygous LIS1 mutations or hemizygous DCX mutations in males are less common. METHODS: Eighteen unrelated patients with type 1 lissencephaly were clinically and genetically assessed. In addition, patients with subcortical band heterotopia (n = 1) or lissencephaly with cerebellar hypoplasia (n = 2) were included. RESULTS: Fourteen new and seven previously described LIS1 mutations were identified. We observed nine truncating mutations (nonsense, n = 2; frameshift, n = 7), six splice site mutations, five missense mutations, and one in-frame deletion. Somatic mosaicism was assumed in three patients with partial subcortical band heterotopia in the occipital-parietal lobes or mild pachygyria. We report three mutations in exon 11, including a frameshift which extends the LIS1 protein, leading to type 1 lissencephaly and illustrating the functional importance of the WD domains at the C terminus. Furthermore, we present two patients with novel LIS1 mutations in exon 10 associated with lissencephaly with cerebellar hypoplasia type a. CONCLUSION: In contrast to previous reports, our data suggest that neither type nor position of intragenic mutations in the LIS1 gene allows an unambiguous prediction of the phenotypic severity. Furthermore, patients presenting with mild cerebral malformations such as subcortical band heterotopia or cerebellar hypoplasia should be considered for genetic analysis of the LIS1 gene.